Received: 15 July 2021
Accepted: 24 September 2021
First Online: 19 October 2021
Change Date: 9 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S10194-021-01346-Z
: This study was approved by the medical ethics committee of Leiden University Medical Center. All subjects provided written informed consent.
: Not applicable.
: I.E. Verhagen has received research grants from ZonMw and the Dutch Brain Foundation. R.B. Brandt has received support for conference visits from Allergan. C.M.A. Kruitbosch reports no disclosures. A. MaassenVanDenBrink reports consultancy or industry support from Novartis, Lilly and Teva, and independent support from the Dutch Research Council (VICI grant 09150181910040), The Netherlands Organisation for Health Research and Development (ZonMw) and the Dutch Heart & Brain Foundations. R. Fronczek has received consultancy support from Novartis, Lilly, Teva, Allergan, and independent support from the Dutch Brain Foundation and Innovation Fund Dutch Healthcare Providers. G.M. Terwindt reports consultancy support from Novartis, Allergan, Lilly, and Teva, and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte.